Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.
Nie JH, Yang T, Li H, Li S, Li TT, Ye HS, Lu MD, Chu X, Zhong GQ, Zhou JL, Wu ML, Zhang Y, Liu J.
Nie JH, et al. Among authors: li tt, li s, li h.
Cancer Sci. 2022 Oct;113(10):3618-3632. doi: 10.1111/cas.15521. Epub 2022 Aug 21.
Cancer Sci. 2022.
PMID: 35946078
Free PMC article.